SPC
GILD icon

Sigma Planning Corp’s Gilead Sciences GILD Stock Holding History

Sigma Planning Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Sell
20,278
-7,783
-28% -$1.09M 0.08% 268
2025
Q4 		$3.44M Buy
28,061
+9,038
+48% +$1.1M 0.1% 222
2025
Q3 		$2.11M Sell
19,023
-7,751
-29% -$881K 0.06% 311
2025
Q2 		$2.97M Sell
26,774
-12,373
-32% -$1.32M 0.09% 232
2025
Q1 		$4.39M Sell
39,147
-4,321
-10% -$446K 0.14% 145
2024
Q4 		$4.02M Sell
43,468
-1,126
-3% -$101K 0.13% 167
2024
Q3 		$3.74M Buy
44,594
+693
+2% +$52.9K 0.11% 181
2024
Q2 		$3.01M Buy
43,901
+5,351
+14% +$357K 0.1% 208
2024
Q1 		$2.82M Buy
38,550
+21,581
+127% +$1.66M 0.09% 232
2023
Q4 		$1.37M Sell
16,969
-22,684
-57% -$1.77M 0.11% 205
2023
Q3 		$2.97M Sell
39,653
-1,029
-3% -$79.1K 0.11% 181
2023
Q2 		$3.14M Sell
40,682
-3,988
-9% -$318K 0.11% 186
2023
Q1 		$3.71M Sell
44,670
-7,008
-14% -$580K 0.12% 174
2022
Q4 		$4.44M Sell
51,678
-4,449
-8% -$352K 0.16% 140
2022
Q3 		$3.46M Buy
56,127
+3,197
+6% +$202K 0.13% 166
2022
Q2 		$3.27M Buy
52,930
+16,035
+43% +$993K 0.11% 189
2022
Q1 		$2.19M Buy
36,895
+6,190
+20% +$396K 0.07% 291
2021
Q4 		$2.23M Buy
30,705
+1,420
+5% +$97.8K 0.06% 303
2021
Q3 		$2.05M Sell
29,285
-9,191
-24% -$646K 0.06% 324
2021
Q2 		$2.65M Buy
38,476
+4,416
+13% +$295K 0.08% 267
2021
Q1 		$2.2M Buy
34,060
+321
+1% +$20.7K 0.07% 293
2020
Q4 		$1.97M Sell
33,739
-1,717
-5% -$104K 0.07% 282
2020
Q3 		$2.24M Buy
35,456
+1,417
+4% +$98.3K 0.09% 225
2020
Q2 		$2.62M Buy
34,039
+87
+0.3% +$6.67K 0.12% 182
2020
Q1 		$2.54M Buy
33,952
+9,431
+38% +$652K 0.15% 146
2019
Q4 		$1.59M Buy
24,521
+8,602
+54% +$560K 0.07% 299
2019
Q3 		$1.01M Buy
15,919
+2,181
+16% +$143K 0.05% 369
2019
Q2 		$928K Sell
13,738
-1,505
-10% -$99K 0.05% 356
2019
Q1 		$991K Sell
15,243
-357
-2% -$23.7K 0.06% 320
2018
Q4 		$976K Sell
15,600
-955
-6% -$66.8K 0.07% 267
2018
Q3 		$1.28M Sell
16,555
-7,503
-31% -$567K 0.08% 252
2018
Q2 		$1.7M Sell
24,058
-1,361
-5% -$96.1K 0.11% 194
2018
Q1 		$1.92M Sell
25,419
-5,222
-17% -$415K 0.14% 172
2017
Q4 		$2.19M Buy
30,641
+3,010
+11% +$229K 0.17% 151
2017
Q3 		$2.24M Sell
27,631
-9,160
-25% -$700K 0.18% 139
2017
Q2 		$2.6M Sell
36,791
-3,377
-8% -$225K 0.24% 103
2017
Q1 		$2.73M Buy
40,168
+2,889
+8% +$203K 0.26% 85
2016
Q4 		$2.67M Buy
37,279
+5,995
+19% +$446K 0.29% 71
2016
Q3 		$2.48M Buy
31,284
+6,363
+26% +$517K 0.29% 77
2016
Q2 		$2.08M Buy
24,921
+330
+1% +$29.3K 0.27% 83
2016
Q1 		$2.26M Buy
24,591
+404
+2% +$36.4K 0.31% 72
2015
Q4 		$2.45M Buy
24,187
+6,299
+35% +$655K 0.34% 59
2015
Q3 		$1.76M Sell
17,888
-10,490
-37% -$1.17M 0.28% 80
2015
Q2 		$3.32M Buy
28,378
+3,844
+16% +$420K 0.46% 44
2015
Q1 		$2.41M Sell
24,534
-100
-0.4% -$10.2K 0.32% 67
2014
Q4 		$2.32M Buy
+24,634
New +$2.55M 0.31% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sigma Planning Corp's GILD Position: Q1 2026 in Review

Sigma Planning Corp reduced its Gilead Sciences (GILD) stake by 28% in Q1 2026, selling an estimated $1.09M and leaving 20,278 shares worth $2.83M. The position accounts for 0.08% of the portfolio, ranked #268.

Sigma Planning Corp first reported a position in GILD in Q4 2014 and has held it in 46 quarters since. The position peaked at $4.44M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sigma Planning Corp held 20,278 shares of Gilead Sciences worth $2.83M as of Q1 2026.
  • Sigma Planning Corp sold 7,783 Gilead Sciences shares in Q1 2026, an estimated $1.09M.
  • Gilead Sciences made up 0.08% of Sigma Planning Corp's portfolio in Q1 2026, its #268 holding.
  • Sigma Planning Corp first reported a position in Gilead Sciences in Q4 2014 and has held it in 46 quarters since.
  • Sigma Planning Corp's Gilead Sciences position peaked at $4.44M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.